Abstract
Hepatitis C and HIV represent global health problems. To date, over 35 million people have become infected with HIV. The hepatitis C virus is found generally in 1–3% of the population with an assumed worldwide number of between 60 and 180 million infected persons. Coinfection with hepatitis C virus and HIV frequently occurs because of the same route of transmission via blood and blood products. This applies especially to drug addicts and hemophiliacs. In Germany it is estimated that there are about 5600 HIV/HCV-coinfected patients. In view of the rapid progress of hepatitis C in the presence of HIV infection, especially in advanced immunodeficiency, treatment of hepatitis C in the presence of HIV coinfection is becoming increasingly important. Up to now, however, the poor therapeutic success and considerable side effects of the current forms of treatment (especially interferon-α monotherapy) have been limiting factors. The following paper deals with the data so far collected on the therapeutic possibilities for hepatitis C in HIV- infected hemophiliacs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bochet M, Benhamon Y, Colombat G, et al: Anti-protease inhibitor therapy decreases the liver fibrosis progression rate in HIV-HCV coinfected patients. In: Program and Abstracts of the 7th European Conference on Clinical Aspects and Treatment of HIV-Infection, Lisbon, 1999; 33:248
Busch C, Nagabhairu L, Markowitz M, et al: Changes in HCV viral load in HIV patients during HAART therapy and after therapy failure. In: Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 1999; 192
De Sanctis GM, Errera G, Barbacini G, et al: Long-term outcome of chronic hepatitis infection in HIV± subjects treated with interferon. In: Program and Abstracts of the 9th International Conference on AIDS, Berlin, Germany, 1993:B19
Eyster ME, Fried MB, Di Bisceglie AM, et al: Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020–1023
Marcellin P, Boyer N, Areias J, et al: Comparison of efficacy of α-interferon in former intravenous drug addicts with chronic hepatitis with or without HIV-infection. Gastroenterology 1994; 106:A938
Mariott E, Navas S, del Romero I et al: Treatment with combinant α-interferon of chronic hepatitis C in anti-HIV-positive patients. J Med Virol 1993; 40:107–111
Mauss S, Klinker H, Ulmer A, Willers R, Weißbrich B, Albrecht H, Häussinger D, Jablonowski H: Response to treatment of chronic hepatitis C with interferon a in patients infected with HIV-1 is associated with higher CD4-cell count. Infection 1998; 26:16–19
Piliero PJ, Szebenyi S, Bartholomew C, et al: Recombinant interferon therapy for chronic hepatitis C in patients with HIV. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, 1997:673
Reichard O, Norkrans G, Fryden A, et al: Randomized double-blind placebo-controlled trial of interferon-α 2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351:83–87
Rockstroh JK, Theisen A, Kaiser R et al: Antiretroviral triple therapy decreases HIV-viral load but does not alter hepatitis C virus serum levels in HIV/HCV-coinfected hemophiliacs. AIDS 1998; 12:829–830
Soriano V, Garcia-Samaniego J, Bravo R, et al: Interferon-α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 23:585–591
Zylberberg H, Landau A, Chai XML, et al: Ribavirin does not modify HIV-replication in HCV/HIV-coinfected subjects under antiretroviral regimen. Hepatology 1998; 28:479a
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rockstroh, J.K. (2001). Report on Experience in the Treatment of Hepatitis C in HIV-Coinfected Hemophiliacs. In: Scharrer, I., Schramm, W. (eds) 30th Hemophilia Symposium Hamburg 1999. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18240-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-18240-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67677-5
Online ISBN: 978-3-642-18240-2
eBook Packages: Springer Book Archive